DK0737069T3 - Deuterede aktive stoffer til transdermal administrering - Google Patents

Deuterede aktive stoffer til transdermal administrering

Info

Publication number
DK0737069T3
DK0737069T3 DK95902785T DK95902785T DK0737069T3 DK 0737069 T3 DK0737069 T3 DK 0737069T3 DK 95902785 T DK95902785 T DK 95902785T DK 95902785 T DK95902785 T DK 95902785T DK 0737069 T3 DK0737069 T3 DK 0737069T3
Authority
DK
Denmark
Prior art keywords
active substances
pct
transdermal administration
deuterated
sec
Prior art date
Application number
DK95902785T
Other languages
English (en)
Inventor
Lohmann Therapie-Systeme A Lts
Original Assignee
Lohmann Therapie-Systeme A Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie-Systeme A Lts filed Critical Lohmann Therapie-Systeme A Lts
Application granted granted Critical
Publication of DK0737069T3 publication Critical patent/DK0737069T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95902785T 1993-12-22 1994-12-06 Deuterede aktive stoffer til transdermal administrering DK0737069T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4343838A DE4343838C2 (de) 1993-12-22 1993-12-22 Deuteriertes Arzneimittel in transdermaler Applikation und Verfahren zu seiner Herstellung
PCT/EP1994/004047 WO1995017188A1 (de) 1993-12-22 1994-12-06 Deuterierte wirkstoffe in transdermaler applikation

Publications (1)

Publication Number Publication Date
DK0737069T3 true DK0737069T3 (da) 2003-07-28

Family

ID=6505771

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95902785T DK0737069T3 (da) 1993-12-22 1994-12-06 Deuterede aktive stoffer til transdermal administrering

Country Status (21)

Country Link
US (1) US5895660A (da)
EP (1) EP0737069B1 (da)
JP (1) JP4451494B2 (da)
KR (1) KR100371810B1 (da)
AT (1) ATE237331T1 (da)
AU (1) AU706814B2 (da)
CA (1) CA2179778C (da)
CZ (1) CZ180496A3 (da)
DE (2) DE4343838C2 (da)
DK (1) DK0737069T3 (da)
ES (1) ES2197187T3 (da)
FI (1) FI962550A (da)
HU (1) HUT75700A (da)
IL (1) IL112059A (da)
MY (1) MY111718A (da)
NO (1) NO962655L (da)
NZ (1) NZ277036A (da)
PL (1) PL178036B1 (da)
SK (1) SK82596A3 (da)
WO (1) WO1995017188A1 (da)
ZA (1) ZA9410211B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4427690A1 (de) * 1994-08-04 1996-02-08 Bogdahn Ulrich Prof Deuterium enthaltende pharmazeutische Zusammensetzung als Zytostatikum oder Tumor-Therapeutikum
US6376531B1 (en) 1998-11-13 2002-04-23 Rupert Charles Bell Method of treatment using deuterium compounds
DE10129832A1 (de) * 2001-06-17 2003-07-10 Berolina Drug Dev Ab Svedala Deuterierte N- und alpha-substituierte Diphenylalkoxyessigsäureaminoalkylester sowie diese Verbindungen enthaltende Arzneimittel
US6872408B2 (en) * 2001-09-07 2005-03-29 Rupert C. Bell Method of treating bipolar disorders using deuterium-substituted carbonate
DE10214228A1 (de) * 2002-03-22 2003-10-02 Bdd Group Holding Ag Zug Deuterierte substitutierte Indole sowie diese Verbindungen enthaltende Arzneimittel
CN101528269A (zh) 2006-08-16 2009-09-09 奥斯拜客斯制药有限公司 阿片样物质止痛剂的制备和应用
DE102007031397A1 (de) * 2007-07-05 2009-01-08 D2O Bioscience Group Ltd. Verwendung von Deuteriumoxid zur Behandlung von Virus-basierten Erkrankungen der Haut
BRPI0916769A2 (pt) * 2008-07-15 2017-09-26 Theracos Inc derivados de benzilbenzeno deuterados e métodos de uso
CA2732508C (en) 2008-08-11 2016-03-15 Nektar Therapeutics Multi-arm polymeric alkanoate conjugates
US8658236B2 (en) 2009-08-21 2014-02-25 Deuteria Beverages, Llc Alcoholic compositions having a lowered risk of acetaldehydemia
WO2012088433A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Deuterated and/or fluorinated taxane derivatives
WO2012088422A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
WO2012088445A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
US8778223B2 (en) 2011-05-24 2014-07-15 Lc Vision, Llc Liquid crystals having cyclohexyl core structures and fluorinated tails

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
SE426011B (sv) * 1976-01-30 1982-12-06 Sixten Abrahamsson Anvendning av en helt eller partiellt deutererad acyklisk, enbasisk karboxyylayra for att skydda ett material i form av levande vexter, utsede och tre mot skadliga svampar
US4475585A (en) * 1981-06-11 1984-10-09 Snyder General Corporation Air conditioning and heat pump cabinets with removable coil guards
US4529600A (en) * 1982-09-09 1985-07-16 Sri International Pentadeuterioretinoids
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
US4898855A (en) * 1987-09-14 1990-02-06 Hoffman-La Roche Inc. Deuterated analogs of 1,25-dihydroxycholecalciferol
US4876260A (en) * 1987-10-28 1989-10-24 State Of Israel, Israel Institute Of Biological Research Oxathiolanes
US5075337A (en) * 1989-07-26 1991-12-24 G. D. Searle & Co. Alpha-deuterated 2-alkylaminoacetamide derivatives having reduced toxicity for treatment of CNS disorders
GB9201275D0 (en) * 1992-01-21 1992-03-11 Norsk Hydro As New compounds

Also Published As

Publication number Publication date
IL112059A0 (en) 1995-03-15
DE59410275D1 (de) 2003-05-22
ZA9410211B (en) 1996-02-06
DE4343838A1 (de) 1995-06-29
AU706814B2 (en) 1999-06-24
EP0737069B1 (de) 2003-04-16
EP0737069A1 (de) 1996-10-16
CA2179778C (en) 2005-09-06
CZ180496A3 (en) 1997-02-12
NO962655D0 (no) 1996-06-21
ES2197187T3 (es) 2004-01-01
SK82596A3 (en) 1997-03-05
JPH09506874A (ja) 1997-07-08
US5895660A (en) 1999-04-20
PL178036B1 (pl) 2000-02-29
IL112059A (en) 1999-06-20
NO962655L (no) 1996-08-20
PL315127A1 (en) 1996-10-14
KR100371810B1 (ko) 2003-07-22
DE4343838C2 (de) 1998-07-09
HU9601684D0 (en) 1996-08-28
CA2179778A1 (en) 1995-06-29
WO1995017188A1 (de) 1995-06-29
JP4451494B2 (ja) 2010-04-14
ATE237331T1 (de) 2003-05-15
NZ277036A (en) 1998-06-26
FI962550A0 (fi) 1996-06-19
FI962550A (fi) 1996-08-13
MY111718A (en) 2000-11-30
HUT75700A (en) 1997-05-28
AU1191795A (en) 1995-07-10

Similar Documents

Publication Publication Date Title
BR9406893A (pt) Emprego de nona- e decapeptideos para a preparação de um medicamento para o combate da aids
PT99513A (pt) Processo para a preparacao de composicoes farmaceuticas contendo profarmacos de morfina para administracao topica por via transdermica
DK0737069T3 (da) Deuterede aktive stoffer til transdermal administrering
AR003989A1 (es) Composicion cosmetica o farmaceutica y procedimiento de tratamiento cosmetico, excluido tdo tratamiento terapeutico que utiliza la composicion cosmetica.
EP0693924A4 (en) METHODS OF ADMINISTRATION -i (IN VIVO) OF BIOLOGICAL SUBSTANCES AND COMPOSITIONS USED IN SUCH METHODS
ATE321529T1 (de) Dosierungsform für eine verzögerte und zunehmende wirkstoffsfreisetzung
FI953442A (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
FR2771291B1 (fr) Spheroides, procede de preparation et compositions pharmaceutiques
DK0800386T3 (da) Transdermalt system til samtidig indgivelse af flere aktive stoffer
DK0781281T3 (da) Beta-Carbolinderivater som melatonin-agonister, fremgangsmåder til fremstilling deraf og deres anvendelse som lægemiddel
AR022358A1 (es) Una composicion de epo, un procedimiento para su obtencion, un preparado farmaceutico que la contiene y un procedimiento para aumentar la actividadespecifica de una composicion de epo
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
DK0714304T3 (da) Terapeutisk system til behandling af psoriasis
BR9508021A (pt) Composição farmacêutica para o tratamento de distúrbios esquizofrênicos, uso de um agente imunossupressor, e, processo de tratamento de um paciente esquizofrênico
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
BR9407340A (pt) Meio hormonal para tratamento de acne
PT1231908E (pt) Composicao farmaceutica compreendendo um composto dador de no e sua utilizacao em terapia
ATE293445T1 (de) Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
MX9302986A (es) Medicamento que contiene metrifonato y procedimiento para su preparacion
PT1001942E (pt) Poli-hidroxibutilpirazinas sua preparacao e medicamentos que as contem
BR9710629A (pt) Composi-Æo farmac-utica processo para sua prepara-Æo composto para utiliza-Æo como agente terap-utico e utiliza-Æo e utiliza-Æo de um composto
IT1257479B (it) Derivati prostaglandinici aventi effetti radioprotettivi
MX9400288A (es) Procedimiento para la preparacion de un medicamento util como radiorestaurador.